US Stock MarketDetailed Quotes

Hepion Pharmaceuticals (HEPA)

Watchlist
  • 0.0600
  • 0.00000.00%
15min DelayClose Jan 15 15:38 ET
697.22KMarket Cap-0.01P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hepion Pharmaceuticals (HEPA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
82.29%-445.96K
87.42%-1.38M
69.10%-1.12M
55.45%-18.22M
87.19%-1.15M
77.59%-2.52M
12.12%-10.93M
55.97%-3.62M
-16.96%-40.89M
-87.63%-9M
Net income from continuing operations
90.29%-472.51K
73.44%-1.04M
-113.96%-6.11M
73.04%-13.19M
86.01%-1.55M
53.78%-4.87M
72.12%-3.93M
78.48%-2.85M
-15.94%-48.93M
-62.37%-11.06M
Operating gains losses
29.31%-47.28K
78.71%-698.07K
513.60%4.8M
-523.43%-5.58M
---1.07M
---66.88K
---3.28M
---1.16M
--1.32M
----
Depreciation and amortization
--0
--0
--0
-54.18%30.76K
--0
--0
--0
70.53%30.76K
-13.34%67.13K
-33.62%12.27K
Deferred tax
----
----
----
--0
----
----
----
----
---409.02K
----
Other non cash items
----
----
----
512.70%1.82M
405.48%794.25K
438.98%474.57K
-1,313.48%-1.25M
3,610.29%1.8M
-6.03%-440K
-225.00%-260K
Change In working capital
-96.14%73.82K
98.50%-37.46K
107.83%167.2K
-190.30%-2.68M
102.28%44.34K
310.84%1.91M
-190.26%-2.5M
-170.07%-2.14M
-5.76%2.97M
-205.41%-1.94M
-Change in prepaid assets
-92.79%161.91K
114.49%151.09K
-99.63%1.34K
-30.51%1.86M
135.99%292.36K
368.68%2.24M
-298.98%-1.04M
-85.34%364.26K
191.62%2.68M
-156.03%-812.39K
-Change in payables and accrued expense
73.25%-88.09K
87.18%-188.55K
106.64%165.86K
-1,600.59%-4.55M
77.98%-248.37K
76.22%-329.29K
-165.39%-1.47M
-540.73%-2.5M
-86.51%302.92K
-384.90%-1.13M
-Change in other current assets
--0
--0
--0
136.99%212.88K
201.48%118.3K
--32.43K
--31.29K
-39.00%30.86K
-64.51%89.83K
-20.98%39.24K
-Change in other current liabilities
--0
--0
--0
-116.13%-209.02K
-179.94%-117.95K
-3,648.76%-36.14K
---21.18K
37.05%-33.75K
63.28%-96.71K
18.92%-42.13K
Cash from discontinued investing activities
Operating cash flow
82.29%-445.96K
87.42%-1.38M
69.10%-1.12M
55.45%-18.22M
87.19%-1.15M
77.59%-2.52M
12.12%-10.93M
55.97%-3.62M
-16.96%-40.89M
-87.63%-9M
Investing cash flow
Cash flow from continuing investing activities
0
-4,094.63%-600K
0
-23,337.80%-600K
-1.66%-14.3K
97.87%-348
Net PPE purchase and sale
----
----
----
--0
--0
--0
----
----
-1.66%-14.3K
97.87%-348
Net investment purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net other investing changes
----
----
----
---600K
--0
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
---132.12K
--0
-4,094.63%-600K
--0
-23,337.80%-600K
--0
--0
-1.66%-14.3K
97.87%-348
Financing cash flow
Cash flow from continuing financing activities
-106.29%-157.35K
-154.52K
186.39%5.3M
-3.23%4.35M
0
2.5M
0
1.85M
187.49%4.49M
243.27%4.49M
Net issuance payments of debt
---157.35K
---154.52K
---2.9M
----
----
--0
--0
--0
----
----
Net common stock issuance
----
----
386.56%9M
--2.5M
--0
----
----
--1.85M
--0
--0
Proceeds from stock option exercised by employees
--0
----
----
-58.85%1.85M
--0
--0
--0
--1.85M
--4.49M
--4.49M
Net other financing activities
--0
--0
---802.6K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-106.29%-157.35K
---154.52K
186.39%5.3M
-3.23%4.35M
--0
--2.5M
--0
--1.85M
187.49%4.49M
243.27%4.49M
Net cash flow
Beginning cash position
38.27%2.92M
-65.00%4.59M
-97.25%406.41K
-71.12%14.79M
-92.24%1.5M
-93.07%2.12M
-69.52%13.11M
-71.12%14.79M
-43.96%51.19M
-67.40%19.28M
Current changes in cash
2.37%-603.32K
84.79%-1.66M
336.55%4.18M
60.27%-14.47M
74.42%-1.15M
94.50%-617.93K
12.24%-10.93M
78.49%-1.77M
9.24%-36.41M
43.32%-4.51M
Effect of exchange rate changes
--0
--0
--0
1,634.16%87.12K
593.00%62.18K
99.77%-9
-229.53%-61.75K
361.61%86.71K
110.66%5.02K
288.17%8.97K
End cash Position
55.04%2.32M
38.27%2.92M
-65.00%4.59M
-97.25%406.41K
-97.25%406.41K
-92.24%1.5M
-93.07%2.12M
-69.52%13.11M
-71.12%14.79M
-71.12%14.79M
Free cash flow
82.29%-445.96K
87.42%-1.38M
69.10%-1.12M
55.46%-18.22M
87.19%-1.15M
77.59%-2.52M
12.24%-10.93M
55.97%-3.62M
-16.94%-40.9M
-87.01%-9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 82.29%-445.96K87.42%-1.38M69.10%-1.12M55.45%-18.22M87.19%-1.15M77.59%-2.52M12.12%-10.93M55.97%-3.62M-16.96%-40.89M-87.63%-9M
Net income from continuing operations 90.29%-472.51K73.44%-1.04M-113.96%-6.11M73.04%-13.19M86.01%-1.55M53.78%-4.87M72.12%-3.93M78.48%-2.85M-15.94%-48.93M-62.37%-11.06M
Operating gains losses 29.31%-47.28K78.71%-698.07K513.60%4.8M-523.43%-5.58M---1.07M---66.88K---3.28M---1.16M--1.32M----
Depreciation and amortization --0--0--0-54.18%30.76K--0--0--070.53%30.76K-13.34%67.13K-33.62%12.27K
Deferred tax --------------0-------------------409.02K----
Other non cash items ------------512.70%1.82M405.48%794.25K438.98%474.57K-1,313.48%-1.25M3,610.29%1.8M-6.03%-440K-225.00%-260K
Change In working capital -96.14%73.82K98.50%-37.46K107.83%167.2K-190.30%-2.68M102.28%44.34K310.84%1.91M-190.26%-2.5M-170.07%-2.14M-5.76%2.97M-205.41%-1.94M
-Change in prepaid assets -92.79%161.91K114.49%151.09K-99.63%1.34K-30.51%1.86M135.99%292.36K368.68%2.24M-298.98%-1.04M-85.34%364.26K191.62%2.68M-156.03%-812.39K
-Change in payables and accrued expense 73.25%-88.09K87.18%-188.55K106.64%165.86K-1,600.59%-4.55M77.98%-248.37K76.22%-329.29K-165.39%-1.47M-540.73%-2.5M-86.51%302.92K-384.90%-1.13M
-Change in other current assets --0--0--0136.99%212.88K201.48%118.3K--32.43K--31.29K-39.00%30.86K-64.51%89.83K-20.98%39.24K
-Change in other current liabilities --0--0--0-116.13%-209.02K-179.94%-117.95K-3,648.76%-36.14K---21.18K37.05%-33.75K63.28%-96.71K18.92%-42.13K
Cash from discontinued investing activities
Operating cash flow 82.29%-445.96K87.42%-1.38M69.10%-1.12M55.45%-18.22M87.19%-1.15M77.59%-2.52M12.12%-10.93M55.97%-3.62M-16.96%-40.89M-87.63%-9M
Investing cash flow
Cash flow from continuing investing activities 0-4,094.63%-600K0-23,337.80%-600K-1.66%-14.3K97.87%-348
Net PPE purchase and sale --------------0--0--0---------1.66%-14.3K97.87%-348
Net investment purchase and sale --0------------------0----------------
Net other investing changes ---------------600K--0--------------------
Cash from discontinued investing activities
Investing cash flow --0---132.12K--0-4,094.63%-600K--0-23,337.80%-600K--0--0-1.66%-14.3K97.87%-348
Financing cash flow
Cash flow from continuing financing activities -106.29%-157.35K-154.52K186.39%5.3M-3.23%4.35M02.5M01.85M187.49%4.49M243.27%4.49M
Net issuance payments of debt ---157.35K---154.52K---2.9M----------0--0--0--------
Net common stock issuance --------386.56%9M--2.5M--0----------1.85M--0--0
Proceeds from stock option exercised by employees --0---------58.85%1.85M--0--0--0--1.85M--4.49M--4.49M
Net other financing activities --0--0---802.6K----------------------------
Cash from discontinued financing activities
Financing cash flow -106.29%-157.35K---154.52K186.39%5.3M-3.23%4.35M--0--2.5M--0--1.85M187.49%4.49M243.27%4.49M
Net cash flow
Beginning cash position 38.27%2.92M-65.00%4.59M-97.25%406.41K-71.12%14.79M-92.24%1.5M-93.07%2.12M-69.52%13.11M-71.12%14.79M-43.96%51.19M-67.40%19.28M
Current changes in cash 2.37%-603.32K84.79%-1.66M336.55%4.18M60.27%-14.47M74.42%-1.15M94.50%-617.93K12.24%-10.93M78.49%-1.77M9.24%-36.41M43.32%-4.51M
Effect of exchange rate changes --0--0--01,634.16%87.12K593.00%62.18K99.77%-9-229.53%-61.75K361.61%86.71K110.66%5.02K288.17%8.97K
End cash Position 55.04%2.32M38.27%2.92M-65.00%4.59M-97.25%406.41K-97.25%406.41K-92.24%1.5M-93.07%2.12M-69.52%13.11M-71.12%14.79M-71.12%14.79M
Free cash flow 82.29%-445.96K87.42%-1.38M69.10%-1.12M55.46%-18.22M87.19%-1.15M77.59%-2.52M12.24%-10.93M55.97%-3.62M-16.94%-40.9M-87.01%-9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -